Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study design needs to be updated considering the lack of a risk predictor with acceptable predictive performance for the discrimination between high- and low-risk patients and the overall low sudden cardiac death risk as found in the data analysis

Conditions

Myocardial Infarction
Heart Failure
Sudden Cardiac Death

Interventions

DRUG: Optimal Medical Therapy (OMT)
DEVICE: Implantable cardioverter-defibrillator (ICD)

Sponsor

Helios Health Institute GmbH